| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1582-4934.2006.TB00531.X |
| P698 | PubMed publication ID | 17125591 |
| P50 | author | Enrique Roche | Q57337490 |
| P2093 | author name string | María Isabel Arribas | |
| J A Reig | |||
| A Santana | |||
| R Enseñat-Waser | |||
| P2860 | cites work | Differentiation of insulin-producing cells from human neural progenitor cells | Q21092394 |
| Syntaxin 1 interacts with the L(D) subtype of voltage-gated Ca(2+) channels in pancreatic beta cells | Q24680036 | ||
| Directed differentiation of rhesus monkey ES cells into pancreatic cell phenotypes | Q24802550 | ||
| Triggering and amplifying pathways of regulation of insulin secretion by glucose | Q27863677 | ||
| Molecular mechanisms and regulation of insulin exocytosis as a paradigm of endocrine secretion | Q27876210 | ||
| Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen | Q28141785 | ||
| Regulation of insulin gene transcription | Q28210255 | ||
| Clonal identification of multipotent precursors from adult mouse pancreas that generate neural and pancreatic lineages | Q28278091 | ||
| Combined expression of pancreatic duodenal homeobox 1 and islet factor 1 induces immature enterocytes to produce insulin | Q28567058 | ||
| Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia | Q28583342 | ||
| Transcription factors direct the development and function of pancreatic beta cells | Q28609099 | ||
| Molecular determinants of regulated exocytosis | Q28609688 | ||
| 53BP1 is required for class switch recombination | Q29465541 | ||
| Epithelial-to-Mesenchymal Transition Generates Proliferative Human Islet Precursor Cells | Q29541158 | ||
| Global and societal implications of the diabetes epidemic | Q29614551 | ||
| Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation | Q29614736 | ||
| Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes | Q33181775 | ||
| Five-year follow-up after clinical islet transplantation | Q33218078 | ||
| Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. | Q33944464 | ||
| Glucose sensing in pancreatic beta-cells: a model for the study of other glucose-regulated cells in gut, pancreas, and hypothalamus | Q34124441 | ||
| Glucose-sensing mechanisms in eukaryotic cells. | Q34245438 | ||
| From stem cells to beta cells: new strategies in cell therapy of diabetes mellitus. | Q34253731 | ||
| Islet Regeneration During the Reversal of Autoimmune Diabetes in NOD Mice | Q34276533 | ||
| Expression of Pax4 in embryonic stem cells promotes differentiation of nestin-positive progenitor and insulin-producing cells | Q34328388 | ||
| Human bone marrow mesenchymal stem cells can express insulin and key transcription factors of the endocrine pancreas developmental pathway upon genetic and/or microenvironmental manipulation in vitro | Q34406295 | ||
| Growth inhibitors promote differentiation of insulin-producing tissue from embryonic stem cells | Q34415516 | ||
| Embryo-derived stem cells: of mice and men. | Q34425188 | ||
| Pancreatic duodenal homeobox-1, PDX-1, a major regulator of beta cell identity and function. | Q34427073 | ||
| Human adipose tissue-derived mesenchymal stem cells differentiate into insulin, somatostatin, and glucagon expressing cells. | Q34491740 | ||
| Reversal of diabetes in non-obese diabetic mice without spleen cell-derived beta cell regeneration | Q34504662 | ||
| Islet recovery and reversal of murine type 1 diabetes in the absence of any infused spleen cell contribution | Q34504668 | ||
| Immunological reversal of autoimmune diabetes without hematopoietic replacement of beta cells. | Q34504674 | ||
| Proinsulin in development: New roles for an ancient prohormone. | Q34510776 | ||
| V(D)J recombination: RAG proteins, repair factors, and regulation | Q34667417 | ||
| In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion | Q34967985 | ||
| Gene expression cascades in pancreatic development | Q35029666 | ||
| Reconstructing MYC. | Q35120942 | ||
| In vitro cultivation of human islets from expanded ductal tissue | Q35174217 | ||
| Nuclear transplantation, embryonic stem cells, and the potential for cell therapy | Q35179632 | ||
| Insulin granule dynamics in pancreatic beta cells | Q35184211 | ||
| Incretins, insulin secretion and Type 2 diabetes mellitus | Q35669308 | ||
| Plasticity of adult stem cells | Q35684656 | ||
| Myc: a weapon of mass destruction | Q35745736 | ||
| Nuclear reprogramming: a key to stem cell function in regenerative medicine | Q35876043 | ||
| Differential expression of the two nonallelic proinsulin genes in the developing mouse embryo | Q36059091 | ||
| Differentiation of rat marrow mesenchymal stem cells into pancreatic islet beta-cells | Q36076469 | ||
| How to make pancreatic beta cells--prospects for cell therapy in diabetes | Q36220822 | ||
| Insulin-secreting cells derived from stem cells: clinical perspectives, hypes and hopes | Q36368247 | ||
| Growing new endocrine pancreas in situ | Q36424061 | ||
| Are there pancreatic progenitor cells from which new islets form after birth? | Q36577005 | ||
| The development of diabetes in E2f1/E2f2 mutant mice reveals important roles for bone marrow-derived cells in preventing islet cell loss | Q36689966 | ||
| The use of gating technology in bioengineering insulin-secreting cells from embryonic stem cells | Q37323527 | ||
| Glucagon-like peptide-1 enhances production of insulin in insulin-producing cells derived from mouse embryonic stem cells | Q40389281 | ||
| Similarities of K+ATP channel expression and Ca2+ changes in pancreatic beta cells and hypothalamic neurons | Q40443990 | ||
| Retinoic acid induces Pdx1-positive endoderm in differentiating mouse embryonic stem cells | Q40483254 | ||
| AMP-activated protein kinase: a new beta-cell glucose sensor?: Regulation by amino acids and calcium ions | Q40488463 | ||
| Regulated expression of pdx-1 promotes in vitro differentiation of insulin-producing cells from embryonic stem cells | Q40521874 | ||
| Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells | Q40544422 | ||
| Development of definitive endoderm from embryonic stem cells in culture | Q40582761 | ||
| Insulin expressing cells from differentiated embryonic stem cells are not beta cells | Q40589116 | ||
| Nestin-lineage cells contribute to the microvasculature but not endocrine cells of the islet | Q40630843 | ||
| PDX-1 induces differentiation of intestinal epithelioid IEC-6 into insulin-producing cells. | Q40715041 | ||
| Generation of purified neural precursors from embryonic stem cells by lineage selection | Q41008017 | ||
| Mechanisms of action of nonglucose insulin secretagogues | Q41053123 | ||
| Transforming growth factor (TGF)beta, fibroblast growth factor (FGF) and retinoid signalling pathways promote pancreatic exocrine gene expression in mouse embryonic stem cells | Q41862814 | ||
| Unprocessed proinsulin promotes cell survival during neurulation in the chick embryo. | Q43901627 | ||
| Overexpression of c-Myc in beta-cells of transgenic mice causes proliferation and apoptosis, downregulation of insulin gene expression, and diabetes | Q44007215 | ||
| Retinoic acid signaling is required for a critical early step in zebrafish pancreatic development | Q44101109 | ||
| NeuroD-betacellulin gene therapy induces islet neogenesis in the liver and reverses diabetes in mice | Q44409461 | ||
| Analysis of insulin-producing cells during in vitro differentiation from feeder-free embryonic stem cells | Q44418714 | ||
| Bone marrow-derived stem cells initiate pancreatic regeneration. | Q44486484 | ||
| Little evidence of transdifferentiation of bone marrow-derived cells into pancreatic beta cells | Q44536342 | ||
| No evidence for significant transdifferentiation of bone marrow into pancreatic beta-cells in vivo | Q44779240 | ||
| Differentiation of human embryonic stem cells into insulin-producing clusters | Q44903372 | ||
| Artifactual insulin release from differentiated embryonic stem cells | Q45077937 | ||
| Committing embryonic stem cells to early endocrine pancreas in vitro | Q45173529 | ||
| The in vitro differentiation of rat neural stem cells into an insulin-expressing phenotype | Q45185279 | ||
| Embryonic stem cells differentiate into insulin-producing cells without selection of nestin-expressing cells. | Q45189356 | ||
| In vitro generation of insulin-producing beta cells from adult exocrine pancreatic cells | Q45199702 | ||
| Reversal of experimental diabetes by multiple bone marrow transplantation | Q45238329 | ||
| Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice | Q45868872 | ||
| Inducing embryonic stem cells to differentiate into pancreatic beta cells by a novel three-step approach with activin A and all-trans retinoic acid | Q46453422 | ||
| Differentiation of in vitro-modified human peripheral blood monocytes into hepatocyte-like and pancreatic islet-like cells | Q46531971 | ||
| Induction of differentiation of embryonic stem cells into insulin-secreting cells by fetal soluble factors. | Q46658312 | ||
| Hypothalamic glucose sensor: similarities to and differences from pancreatic beta-cell mechanisms. | Q48116728 | ||
| Distribution and phenotype of neurons containing the ATP-sensitive K+ channel in rat brain | Q48337960 | ||
| Isolation and characterization of residual undifferentiated mouse embryonic stem cells from embryoid body cultures by fluorescence tracking | Q48930639 | ||
| Insulinotropic hormone glucagon-like peptide-1 differentiation of human pancreatic islet-derived progenitor cells into insulin-producing cells. | Q52117012 | ||
| Spontaneous human adult stem cell transformation. | Q53358878 | ||
| In vitro directed differentiation of mouse embryonic stem cells into insulin-producing cells. | Q53888618 | ||
| Recruitment of Bone Marrow-Derived Endothelial Cells to Sites of Pancreatic -Cell Injury | Q57720869 | ||
| More than just proliferation: Myc function in stem cells | Q58379812 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 866-883 | |
| P577 | publication date | 2006-10-01 | |
| P1433 | published in | Journal of Cellular and Molecular Medicine | Q1524063 |
| P1476 | title | Insulin-producing cells derived from stem cells: recent progress and future directions | |
| P478 | volume | 10 |
| Q38085695 | Adipose-derived mesenchymal stem cells and regenerative medicine |
| Q43111293 | Beta cell coupling and connexin expression change during the functional maturation of rat pancreatic islets |
| Q34374773 | Evaluating protocols for embryonic stem cell differentiation into insulin-secreting beta-cells using insulin II-GFP as a specific and noninvasive reporter |
| Q34132912 | Identification of microRNAs expressed highly in pancreatic islet-like cell clusters differentiated from human embryonic stem cells. |
| Q33316754 | Immunohistochemical analysis of neuroendocrine (NE) differentiation in testicular germ cell tumors (GCTs): use of confocal laser scanning microscopy (CLSM) to demonstrate direct NE differentiation from GCTs |
| Q27693217 | Induced pluripotent stem cells as a model for accelerated patient- and disease-specific drug discovery. |
| Q37445891 | Infusion of UVB-treated splenic stromal cells induces suppression of beta cell antigen-specific T cell responses in NOD mice |
| Q34591457 | Insulin-producing cells could not mimic the physiological regulation of insulin secretion performed by pancreatic beta cells |
| Q36884245 | Molecular and cellular key players in human islet transplantation |
| Q36710960 | Myt1 and Ngn3 form a feed-forward expression loop to promote endocrine islet cell differentiation |
| Q37276010 | Peripheral blood monocytes can differentiate into efficient insulin-producing cells in vitro |
| Q38191830 | Pluripotent stem cells as a potential tool for disease modelling and cell therapy in diabetes. |
| Q33719099 | Recent progress on normal and malignant pancreatic stem/progenitor cell research: therapeutic implications for the treatment of type 1 or 2 diabetes mellitus and aggressive pancreatic cancer |
| Q37089825 | Recent progress on tissue-resident adult stem cell biology and their therapeutic implications |
| Q33982394 | Stem cells as a therapeutic target for diabetes. |
| Q40321403 | Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: a pilot study |
| Q36269896 | Uncovering stem cell differentiation factors for salivary gland regeneration by quantitative analysis of differential proteomes |
Search more.